1. Alshawa K, Beretti JL, Lacroix C, et al. Successful identification of clinical dermatophyte and neoscytalidium species by matrix-assisted laser desorption ionization–time of flight mass spectrometry. J Clinical Microbiol 2012; 50: 2277-81.
2.
Grumbt M, Monod M, Yamada T, et al. Keratin degradation by dermatophytes relies on cysteine dioxygenase and a sulfite efflux pump. J Invest Dermatol 2013; 133: 1550-5.
3.
Havlickova B, Czaika VA, Friedrich M. Epidemiological trends in skin mycoses worldwide. Mycoses 2008; 51: 2-15.
4.
Shalaby MFM, El-Din AN, El-Hamd MA. Isolation, identification, and in vitro antifungal susceptibility testing of dermatophytes from clinical samples at Sohag University Hospital in Egypt. Electron Physician 2016; 8: 2557.
5.
Bolognia JL, Schaffer JV, Cerroni L. Dermatología. Elsevier Health Sciences 2018.
6.
Hay RJ, Ashbee HR. Fungal Infections. In: Rook’s Textbook of Dermatology. Griffiths CEM, Barker J, Bleiker TO, et al. (eds.). Ninth Edition. John Wiley, UK 2016.
7.
Bhat YJ, Keen A, Hassan I, et al. Can dermoscopy serve as a diagnostic tool in dermatophytosis? A pilot study. Indian Dermatol Online J 2019; 10: 530-5.
8.
Rajamohanan R, Raj R, Chellam J, Rengasamy M. Epidemiological trends and clinicomycological profile of chronic dermatophytosis: a descriptive study from south india. Indian J Dermatol 2021; 66: 445.
9.
Garrido-Mesa N, Zarzuelo A, Gálvez J. Minocycline: far beyond an antibiotic. Br J Pharmacol 2013; 169: 337-52.
10.
Rengasamy M, Shenoy MM, Dogra S, et al. Indian Association of Dermatologists, Venereologists and Leprologists (IADVL) Task Force against Recalcitrant Tinea (ITART) Consensus on the Management of Glabrous Tinea (INTACT). Indian Dermatol Online J 2020; 11: 502-19.
11.
Dogra S, Uprety S. The menace of chronic and recurrent dermatophytosis in India: Is the problem deeper than we perceive? Indian Dermatol Online J 2016; 7: 73-6.
12.
de Sousa Mda G, Santana GB, Criado PR, Benard G. Chronic widespread dermatophytosis due to Trichophyton rubrum: a syndrome associated with a Trichophyton-specific functional defect of phagocytes. Front Microbiol 2015; 6: 801.
13.
Vermout S, Tabart J, Baldo A, et al. Pathogenesis of dermatophytosis. Mycopathologia 2008; 166: 267-75.
14.
Oliveira CB, Vasconcellos C, Sakai-Valente NY, et al. Toll-like receptors (TLR) 2 and 4 expression of keratinocytes from patients with localized and disseminated dermatophytosis. Rev Inst Med Trop Sao Paulo 2015; 57: 57-61.
15.
Alves SH, Lopes JO, Costa JM, Klock C. Development of secondary resistance to fluconazole in Cryptococcus neoformans isolated from a patient with AIDS. Rev Inst Med Trop Sao Paulo 1997; 39: 359-62.
16.
Marichal P, Koymans L, Willemsens S, et al. Contribution of mutations in the cytochrome P450 14a-demethylase (Erg11p, Cyp51p) to azole resistance in Candida albicans. Microbiology 1999; 145: 270.
17.
Alhamdi D, AlHamdi K. Recurrent dermatophytosis, new treatment modality: Q-switched ND YAG for recurrent dermatophytosis. J Pakistan Assoc Dermatol 2024; 34: 46-50.
18.
Alhamdi DK, Alhamdi KI. Efficacy and safety of adding low-dose isotretinoin to itraconazole in the treatment of chronic recurrent dermatophytosis among sample of Iraqi patients: an open-labelled therapeutic clinical comparative study. Indian J Dermatol 2022; 67: 624.
19.
Tan L, Shi H, Chen M, et al. In vitro synergistic effect of minocycline combined with antifungals against Cryptococcus neoformans. J Mycol Med 2022; 32: 101227.
20.
Shi W, Chen Z, Chen X, et al. The combination of minocycline and fluconazole causes synergistic growth inhibition against Candida albicans: an in vitro interaction of antifungal and antibacterial agents. FEMS Yeast Res 2010; 10: 885-93.
21.
Flowers L, Witte L, Zurowski SM. Successful treatment of cutaneous scedosporium prolificans: an emerging and treatment-resistant fungal pathogen. Cureus 2023; 15: e44738.
